Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Sperati, Francesca ^a   Vici, Patrizia ^a   Maugeri Saccà, Marcello ^a   Stranges, Saverio ^b   Santesso, Nancy ^c   Mariani, Luciano ^a   Giordano, Antonio ^d   Sergi, Domenico ^a   Pizzuti, Laura ^a   Di Lauro, Luigi ^a   Montella, Maurizio ^e   Crispo, Anna ^e   Mottolese, Marcella ^a   Barba, Maddalena ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d TEMPLE UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; COLECALCIFEROL; PLACEBO; VITAMIN D;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FRAGILITY FRACTURE; HUMAN; META ANALYSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

BREAST NEOPLASMS; DIETARY SUPPLEMENTS; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84880669599     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069269     Document Type: Article

References (127)

1. Grant WB, (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results. Cancer Res 164: 371-377.
2. Zittermann A, Schleithoff SS, Koerfer R, (2005) Putting vitamin D and cardiovascular diseases into perspective. Br J Nutr 94(4): 483-492.
3. Holick MF, (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-71.
4. Giovannucci E, (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16: 83-95.
5. Garland CF, Grant W, Mohr SB, Gorham ED, Garland FC, (2007) What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 65: S91-5.
6. Garland FC, Garland CF, Gorham ED, Young JF, (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-22.
7. Gorham ED, Garlkand FC, Garland CF, (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19: 820-4.
8. Grant WB, (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer Causes Control 94: 272-81.
9. Boscoe FP, Schymura MJ, (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States 1993-2002. BMC Cancer 6: 264.
10. Van der Wielen LM, van den Berg H, de Groot LCPGM, van Staveren WA, Löwik MRH, et al. (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346(8969): 207-10.
11. Lips P, Duong T, Oleksik A, Black D, Cummings,S et al, (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86(3): 1212-21.
12. Yin L, Grandi N, Raum E, Haug U, Arndt V, et al. (2010) Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46: 2196-205.
13. Mohr SB, Gorham E, Alcaraz JE, Kane CJ, Macera CA, et al. (2011) Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res 31: 2939-48.
14. Fedirko V, Torres-Mejía G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, et al. (2012) Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 23: 1149-62.
15. Amir E, Cecchini R, Ganz PA, Costantino JP, Beddows S, et al. (2012) 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat 133: 1077-88.
16. Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett W, C et al, (2011) Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res Treat 13: R50.
17. Kühn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, et al. (2013) Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: A nested case-control study. Int J Cancer doi: 10.1002/ijc.28172. 2013.
18. Autier P, Gandini S, (2007) Vitamin D Supplementation and Total Mortality. Arch Intern Med 167(16): 1730-1737.
19. Trivedi DP, Doll R, Khaw KT, (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 326 (7387): 469-472.
20. Wactawski-Wende J, Kotchen J, Anderson GL, Assaf AR, Brunner RL, et al. (2006) Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354 (7) 684-696.
21. Lappe J, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP, (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85(6): 1586-91.
22. Chlebowski RT, Johnson K, Kooperberg C, Pettinger M, Wactawski-Wende J, et al. (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 19 100(22): 1581-91.
23. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA, (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155(12): 827-38.
24. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, et al. (2012) Vitamin d with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin d trials. J Clin Endocrinol Metab 97(8): 2670-81.
25. Wong SS, Wilczynski N, Haynes RB, (2006) Comparison of top-performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE. J Med Libr Assoc 94(4): 451-5.
26. Parmar M, Torri V, Stewart L, (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-34.
27. Higgins JP, Altman D, Gøtzsche PC, Jüni P, Moher D, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928 doi: 10.1136/bmj.d5928.
28. Sutton AJ, Abrams R, Jones DR, Sheldon TA, Song F (2000) Methods for Meta-Analysis in Medical Research. Chichester, UK: Wiley.
29. Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Collaboration C. Wiley-Blackwell.
30. Avenell A, ManLennan G, Jenkinson DJ, McPherson GC, McDonald AM, et al. (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 97(2): 614-22.
31. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, et al. (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. American Journal of Epidemiology 171(8): 903-8.
32. Roh JL, Park JY, Park CI, (2009) Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer 115(32): 251-258.
33. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME, (2010) The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circulation: Heart Failure 3(2): 195-201.
34. Zhou W, Suk R, Liu G, Park S, Neuberg DS, et al. (2005) Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 14(10): 2303-9.
35. Zhou FL, Zhang WG, Cao XM, Chen YX, He AL, et al. (2008) Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen. [Chinese]. Journal of experimental hematology 13(5): 8961-6.
36. Hollis BW, Wagner CL (2004) Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Cli Nutr 1752S-8S.
37. Inanir A, Ozoran K, Tutkak H, Mermerci B, (2004) The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. Journal of International Medical Research 32(6): 570-582.
38. Harvey JA, Holm MK, Ranganath R, Guse PA, Trott EA, et al. (2009) The effects of bazedoxifene on mammographie breast density in postmenopausal women with osteoporosis. Menopause 16(6): 1193-1196.
39. Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, et al. (2009) Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: A randomized, double-blind, placebo-controlled clinical trial. Cancer Prevention Research 2(3): 212-23.
40. Freedman DM, Tangrea JA, Virtamo J, Albanes D, (1999) The effect of beta-carotene supplementation on serum vitamin D metabolite concentrations.Cancer Epidemiol Biomarkers Prev. 8(12): 1115-6.
41. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI, (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Research 70(21): 8587-97.
42. Hartman JJ, (2000) Vitamin D deficiency rickets in children: prevalence and need for community education. Orthop Nurs 19(1): 63-7.
43. Hartman AL, Benjamin JT (2002) An 18-month-old who could not walk: a case report. Clin Pediatr (Phila) 41(9): 731-2; discussion 732-4.
44. Hartman TJ, Albert PS, Snyder K, Slattery ML, Caan B, et al. (2005) The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr 135(2): 252-9.
45. Stern PH, Lucas RC, Seidenfeld J, (1991) Alpha-difluoromethylornithine inhibits bone resorption in vitro without decreasing beta-glucuronidase release. Mol Pharmacol 39(4): 557-62.
46. Sidelnikov E, Bostick RM, Flanders WD, Long Q, Fedirko V, et al. (2010) Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiology Biomarkers and Prevention 19 (4): 1022-1032.
47. Van Veldhuizen PJ, Taylor SA, Williamson S, Drees BM, (2000) Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. Journal of Urology 163(1): 187-190.
48. Verner AM, McGuire W, Craig JS (2007) Effect of taurine supplementation on growth and development in preterm or low birth weight infants. Cochrane Database of Systematic Reviews: Reviews 4(10).
49. Attia S, Eickhoff J, Wilding G, McNeel D, Blank J, et al. (2008) Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer. Clinical Cancer Research 14(8): 2437-2443.
50. Beer TM, Garzotto M, Katovic NM, (2004) High-dose calcitriol and carboplatin in metastatic androgen-independent prostate cancer. American Journal of Clinical Oncology: Cancer Clinical Trials 27(5): 535-541.
51. Beer TM, Javle M, Lam GN, Henner WD, Wong A, et al. (2005) Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of catcitriol, in patients with cancer. Clinical Cancer Research 11(21): 7794-7799.
52. Beer TM, Javle MM, Ryan CW, Garzotto M, Lam GN, et al. (2007) Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemotherapy and Pharmacology 59(5): 581-587.
53. Beer TM, Lalani AS, Lee S, Mori M, Eilers KM, et al. (2008) C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: Results from the ASCENT trial. Cancer 112(11): 2377-2383.
54. Glinghammar B, Venturi M, Rowland IR, Rafter JJ, (1997) Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water-potential risk factors for colon cancer. The American journal of clinical nutrition 66(5): 1277-82.
55. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, et al. (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 3 95(23): 1765-71.
56. Gross C, Stamey T, Hancock S, Feldman D, (1998) Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). Journal of Urology 159(6): 2035-2040.
57. Hager ED, Birkenmeier J, (2006) Stage IV malignant melanoma: Use of deep regional hyperthermia, tamoxifen, interferon-alpha and complementary therapies. Deutsche Zeitschrift fur Onkologie 38(1): 32-34.
58. Hellstrom E, Robert KH, Samuelsson J, (1990) Treatment of myelodysplastic syndromes with retinoic acid and 1alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. European Journal of Haematology 45(5): 255-261.
59. Henriksen DB, Alexandersen P, Hartmann B, Adrian CL, Byrjalsen I, et al. (2009) Four-month treatment with GLP-2 significantly increases hip BMD. A randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD. Bone 45(5): 833-842.
60. Kulbersh JS, Day TA, Gillespie MB, Young MR, (2009) 1alpha,25-Dihydroxyvitamin D3 to skew intratumoral levels of immune inhibitory CD34+ progenitor cells into dendritic cells. Otolaryngology Head and Neck Surgery 140(2): 235-240.
61. Jacobs ET, Jurutka PW, Martinez ME, Alberts DS, (2009) Vitamin D, calcium, and colorectal neoplasia: New insights on mechanisms of action. Cancer Prevention Research 2(3): 197-199.
62. Yoshida Y, Oguma S, Uchino H, Maekawa T, Nomura T, (1993) A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. A Japanese cooperative study. International Journal of Clinical Pharmacology Research 13(1): 21-7.
63. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, et al. (2007) Intakes of calcium and vitamin D and breast cancer risk in women 2007. Archives of Internal Medicine 167 (10): 1050-9.
64. Neuhouser ML, Kristal AR, Patterson RE, Goodman PJ, Thompson IM, (2001) Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials. Nutr Cancer 39(1): 12-8.
65. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews 4(10).
66. Grober U, (2009) Preventing chronic diseases with vitamin D3. [German]. Deutsche Apotheker Zeitung 149 (25): 62-69.
67. Kerst A, (2007) Vitamin D supplementation reduces the incidence of cancer- A randomized study. [Dutch]. Geneesmiddelenbulletin 41(12): 133-134.
68. Ingraham BA, Bragdon B, Nohe A, (2008) Molecular basis of the potential of vitamin D to prevent cancer. Current Medical Research and Opinion 24(1): 139-149.
69. Jacobs TP, Bilezikian JP, (2005) Clinical review: Rare causes of hypercalcemia. Journal of Clinical Endocrinology and Metabolism 90(11): 6316-6322.
70. Lehmann B, Querings K, Reichrath J, (2004) Vitamin D and skin: New aspects for dermatology. Experimental Dermatology 13S(4): 11-5.
71. Millen AE, Wactawski-Wende J, Pettinger M, Melamed ML, Tylavsky FA, et al. (2010) Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. American Journal of Clinical Nutrition 91: 1324-1335.
72. Raimondi S, Johansson H, Maisonneuve P, Gandini S, (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30(7): 1170-1180.
73. Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, et al. (2007) Lifestyle Factors and Duration of Androgen Deprivation Affect Bone Mineral Density of Patients with Prostate Cancer During First Year of Therapy. Urology 70(1): 122-126.
74. Schumann SA, Ewigman B, (2007) Double-dose vitamin D lowers cancer risk in women over 55. J Fam Pract 56(11): 907-10.
75. Schwartz GG, Skinner HG, (2007) Vitamin D status and cancer: New insights. Current Opinion in Clinical Nutrition and Metabolic Care 10(1): 6-11.
76. Schwartz GG, Blot WJ, (2006) Vitamin D status and cancer incidence and mortality: Something new under the sun. Journal of the National Cancer Institute 98(7): 428-430.
77. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, et al. (2006) Vitamin D and cancer. Anticancer Res 26(4A): 2515-24. Review.
78. Williamson CS, (2006) Vitamin D, sunlight and cancer. Nutrition Bulletin 31(2): 77-80.
79. Dizdar O, Bulut N, Altundag K, (2007) Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer. Breast 17(2): 120.
80. Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, et al. (2007) A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clinical Cancer Research 13(4): 1216-1223.
81. Frost P, D'Anglure BS, (2009) Black-white differences in cancer risk and the vitamin D hypothesis. Journal of the National Medical Association 101(12): 1310-1312.
82. Galan P, Favier A, Preziosi P, Bertrais S, Arnault N, et al. (2003) [The bank of biological material in the SU.VI.MAX study]. Rev Epidemiol Sante Publique 51(1 Pt 2): 147-50.
83. Goodwin PJ, (2009) Vitamin D in cancer patients: Above all, do no harm. Journal of Clinical Oncology 27(13): 2117-2119.
84. Grant WB, (2009) Commentary: Ecologic studies in identifying dietary risk factors for coronary heart disease and cancer. International Journal of Epidemiology 37(6): 1209-1211.
85. Grant WB, (2008) Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3. 1 Am J Pathol 173(5): 1589-90.
86. Harstrick A, Perschl A, (2000) Tumor angiogenesis- Therapeutic implications. Inhibition with integrin antagonists- A new therapeutic approach. [German]. Onkologe 6(5): 443-449.
87. Holick MF (2006) Calcium plus vitamin D and the risk of colorectal cancer. New England Journal of Medicine 354(21): 2287-8; author reply 2287-8.
88. Holt PR, Arber N, Halmos B, Forde K, Kissileff H, et al. (2002) Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiology Biomarkers and Prevention. 11(1): 113-119.
89. Glen H, Cassidy J, (2006) Vitamin D (and its analogs) in the treatment and prevention of cancer. Expert Review of Anticancer Therapy 6(3): 305-308.
90. Price N, D'Orazio A, Jain VK, Sartor O, (2004) The Development of Vitamin D-Based Therapies for ProstateCancer. Clinical Prostate Cancer 2(4): 202-205.
91. Ji Y, Kutner A, Verstuyf A, Verlinden L, Studzinski GP, (2002) Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle 1(6): 410-5.
92. Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, et al. (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24(22): 3629-35.
93. Prentice RL, Anderson GL, (2008) The women's health initiative: Lessons learned. Annual Review of Public Health 29: 131-50.
94. Qiao S, Pennanen P, Nazarova N, Lou YR, Tuohimaa P, (2003) Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells J Steroid Biochem Mol Biol. 85(1): 1-8.
95. Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, et al. (2008) Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prevention Research 1(4): 275-284.
96. Hercberg S, Preziosi P, Galan P, Faure H, Arnaud J, et al. (1999) "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. Supplementation on Vitamines et Minéraux AntioXydants. Food Chem Toxicol 37(9-10): 925-30.
97. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, et al. (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med Nov 22; 164(21): 2335-42. Erratum in: Arch Intern Med. 2005 Feb 14 165(3): 286.
98. Hercberg S, Czernichow S, Galan P, (2006) Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study. Br J Nutr 96Suppl 1: S28-30.
99. Hercberg S, Ezzedine K, Guinot C, Preziosi P, Galan P, et al. (2007) Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137(9): 2098-105.
100. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, et al. (2006) Low-fat dietary pattern and risk of cardiovascular disease: The Women's Health Initiative randomized controlled dietary modification trial. Journal of the American Medical Association 295(6): 655-66.
101. Markopoulos C, Tzoracoleftherakis E, Polychronis A, Venizelos B, Dafni U, et al. (2010) Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast cancer research 12(2): R24. Epub 2010 Apr 16.
102. Schilsky RL, Allen J, Benner J, Sigal E, McClellan M, (2010) Commentary: tackling the challenges of developing targeted therapies for cancer. Oncologist 15(5): 484-7.
103. Ellis GK, Bone HG, Chlebowski R, Paul D, Spadafora S, et al. (2008) Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. Journal of Clinical Oncology 26(30): 4875-4882.
104. Femiano F, Gombos F, Scully C, Battista C, Belnome G, et al. (2001) Oral leukoplakia: open trial of topical therapy with calcipotriol compared with tretinoin. International Journal of Oral and Maxillofacial Surgery 30(5): 402-406.
105. Hines SL, Mincey B, Dentchev T, Sloan JA, Perez EA, et al. (2009) Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Research and Treatment 117(3): 603-609.
106. Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, et al. (2009) Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol 1; 27(7): 1047-53. Epub 2008 Dec 15.
107. Hines SL, Jorn HK, Thompson KM, Larson JM, (2010) Breast cancer survivors and vitamin D: a review. Nutrition 26(3): 255-62.
108. Recker RR, Davies KM, Dowd RM, Heaney RP, (1999) The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Annals of Internal Medicine 130(11): 897-904.
109. Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, et al. (2006) Low-fat dietary pattern and risk of colorectal cancer: The Women's Health Initiative randomized controlled dietary modification trial 295. (6): 643-654.
110. Ding EL, Mehta S, Fawzi WW, Giovannucci EL, (2008) Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: Reanalysis of Women's Health Initiative randomized trial. International Journal of Cancer 122(8): 1690-1694.
111. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, et al. (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. Journal of the National Cancer Institute 90(6): 440-6.
112. LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, et al. (2009) Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci 64(5): 559-67.
113. Pritchard RS, Baron JA, Gerhardsson De Verdier M, (1996) Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiology Biomarkers and Prevention 5(11): 897-900.
114. Sieg J, Sieg A, Dreyhaupt J, Schmidt-Gayk H, (2006) Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis. Anticancer Res 26(4A): 2729-33.
115. Skinner HG (2008) Vitamin D for the treatment and prevention of pancreatic cancer. Cancer Biol Ther 7(3): 437-9. Epub 2008 Apr 10.
116. Woo TCS, Choo R, Jamieson M, Chander S, Vieth R, (2005) Pilot study: Potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy. Nutrition and Cancer 51(1): 32-6.
117. Wood HM, Carducci MA, (2000) Differentiation therapy for prostate cancer. Prostate Journal 2(1): 6-13.
118. Garssen J, Norval M, el-Ghorr A, Gibbs NK, Jones CD, et al. (1998) Estimation of the effects of increasing UVB exposure on the human immune system and related resistance to infectious diseases and tumours. J Photochem Photobiol B 42(3): 167-79.
119. Clinical Trial Website. Calcium and vitamin D malnutrition in elderly women.Available: www.clinicaltrials.gov. Accessed 2013 June 17.
120. The Lancet Website. Available: http://www.thelancet.com/protocol-reviews/02PRT-35. Accessed 2013 June 17.
121. Egger M, Smith GD, Altman DG (2001) Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Books.
122. Bischoff-Ferrari HA, Willett WC, Dietrich T, Dawson-Hughes B, (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1): 18-28.
123. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7): 1911-30. Epub 2011 Jun 6. Erratum in: J Clin Endocrinol Metab. 2011 Dec 96(12): 3908.
124. Forman MR, (2006) LevinB (2006) Calcium plus vitamin D3 supplementation and colorectal cancer in women. N Engl J Med 16 354(7): 752-4.
125. Finkelstein JS, (2006) Calcium plus vitamin D3 supplementation Calcium plus Vitamin D for Postmenopausal Women - Bone Appétit? N Engl J Med 354(7): 750-2.
126. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, et al. (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33(1): 159-71.
127. Current Controlled Trial website. Available: http://www.controlled-trials.com/ISRCTN46328341. Accessed 2013 June 17.